eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Would you have Fainting when you have Birth control?

Summary: Fainting is found among people with Birth control, especially people who are female, 20-29 old, also have Contraception, and take medication Mirena.

We study 699 people who have Fainting and Birth control from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone: join a support group for people who have Birth control and Fainting >>>


Birth control

Birth control can be treated by Yaz, Mirena, Depo-provera, Nuvaring, Yasmin, Loestrin 24 Fe. (latest reports from 106,023 Birth Control patients)


Fainting (loss of consciousness and postural tone) has been reported by people with high blood pressure, depression, osteoporosis, pain, multiple sclerosis. (latest reports from 49,839 Fainting patients)

On Apr, 13, 2015: 699 people who have birth control and Fainting are studied.

Trend of Fainting in birth control reports

Age of people who have birth control and experienced Fainting * :


Severity of the symptom * :

leastmoderateseveremost severe

Top co-existing conditions for these people * :

  1. Contraception (699 people, 100.00%)
  2. Premenstrual syndrome (25 people, 3.58%)
  3. Depression (23 people, 3.29%)
  4. Acne (23 people, 3.29%)
  5. Headache (19 people, 2.72%)
  6. Anxiety (16 people, 2.29%)
  7. Hypothyroidism (15 people, 2.15%)
  8. Pain (15 people, 2.15%)
  9. Migraine (14 people, 2.00%)
  10. Hypersensitivity (13 people, 1.86%)

Most common drugs used by these people * :

  1. Mirena (187 people, 26.75%)
  2. Yasmin (170 people, 24.32%)
  3. Nuvaring (150 people, 21.46%)
  4. Yaz (112 people, 16.02%)
  5. Ortho evra (54 people, 7.73%)
  6. Depo-provera (30 people, 4.29%)
  7. Implanon (28 people, 4.01%)
  8. Lexapro (27 people, 3.86%)
  9. Singulair (25 people, 3.58%)
  10. Drospirenone and ethinyl estradiol (20 people, 2.86%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of birth control and fainting on

Do you have Birth Control and Fainting?




You are not alone! Join a support group on :
- support group for people who have Fainting and Birth control
- support group for people who have Birth control
- support group for people who have Fainting

Could your drug cause:

Other conditions that could cause:

Recent related drug studies (Check your drugs):

Recent Birth Control related drug comparison:

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.